Last reviewed · How we verify
Comparator: Usual Care
Usual Care is a comparator arm representing standard clinical management without the investigational intervention.
At a glance
| Generic name | Comparator: Usual Care |
|---|---|
| Sponsor | Organon and Co |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
Usual Care serves as a control group in clinical trials, representing the baseline standard of care or treatment that patients would normally receive. It allows researchers to measure the efficacy and safety of an investigational drug by comparing outcomes against what patients experience with conventional management. The specific interventions in Usual Care vary by therapeutic area and trial design.
Approved indications
Common side effects
Key clinical trials
- "Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition" (NA)
- Induction of Labor by Cervical Ripening and Transcutaneous Electrical Nerve Stimulation (TENS) (NA)
- Population Health Approach to Optimizing Medications in Older Adults (NA)
- Improving Prenatal Care to Reduce Early Onset Preeclampsia in Low-Income (NA)
- A Clinical Study of Dihydroergotine Mesylate Extended-release Tablets for the Treatment of Drooling in Parkinson's Disease. (PHASE4)
- Inhaled Budesonide for REcurrence Prevention and Adjuvant THerapy in Checkpoint Inhibitor Pneumonitis (PHASE2)
- Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 Trial (NA)
- Optimizing the Diagnostic Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-1 Trial (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Comparator: Usual Care CI brief — competitive landscape report
- Comparator: Usual Care updates RSS · CI watch RSS
- Organon and Co portfolio CI